Barclays PLC Solid Biosciences Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
SELL
$0.51 - $7.56 $811 - $12,035
-1,592 Reduced 2.34%
66,564 $31,000
Q2 2022

Aug 12, 2022
SELL
$0.43 - $1.24 $4,162 - $12,003
-9,680 Reduced 12.44%
68,156 $42,000
Q1 2022

May 16, 2022
SELL
$0.74 - $1.79 $46,393 - $112,222
-62,694 Reduced 44.61%
77,836 $93,000
Q4 2021

Feb 14, 2022
BUY
$1.69 - $2.46 $41,699 - $60,698
24,674 Added 21.3%
140,530 $246,000
Q3 2021

Nov 09, 2021
BUY
$2.38 - $3.77 $65,835 - $104,285
27,662 Added 31.36%
115,856 $277,000
Q2 2021

Aug 13, 2021
SELL
$3.49 - $5.51 $2.04 Million - $3.23 Million
-585,718 Reduced 86.91%
88,194 $322,000
Q1 2021

May 13, 2021
BUY
$5.37 - $10.72 $3.49 Million - $6.96 Million
649,544 Added 2665.56%
673,912 $3.73 Million
Q4 2020

Feb 11, 2021
SELL
$3.08 - $7.79 $7,071 - $17,885
-2,296 Reduced 8.61%
24,368 $185,000
Q3 2020

Nov 12, 2020
SELL
$2.02 - $3.08 $4,690 - $7,151
-2,322 Reduced 8.01%
26,664 $54,000
Q2 2020

Aug 12, 2020
BUY
$2.1 - $3.42 $47,138 - $76,768
22,447 Added 343.28%
28,986 $84,000
Q1 2020

May 13, 2020
SELL
$2.31 - $4.43 $96,047 - $184,194
-41,579 Reduced 86.41%
6,539 $15,000
Q4 2019

Feb 10, 2020
BUY
$2.82 - $12.9 $108,101 - $494,508
38,334 Added 391.8%
48,118 $214,000
Q3 2019

Nov 14, 2019
SELL
$4.33 - $11.64 $96,074 - $258,268
-22,188 Reduced 69.4%
9,784 $101,000
Q2 2019

Aug 14, 2019
SELL
$4.6 - $10.13 $1.82 Million - $4.02 Million
-396,596 Reduced 92.54%
31,972 $184,000
Q1 2019

May 15, 2019
BUY
$7.19 - $32.37 $3.08 Million - $13.9 Million
427,981 Added 72909.88%
428,568 $3.94 Million
Q4 2018

Feb 14, 2019
SELL
$21.32 - $46.34 $126,662 - $275,305
-5,941 Reduced 91.01%
587 $16,000
Q3 2018

Nov 14, 2018
BUY
$36.35 - $51.7 $130,860 - $186,120
3,600 Added 122.95%
6,528 $308,000
Q2 2018

Aug 14, 2018
BUY
$7.33 - $43.15 $7,711 - $45,393
1,052 Added 56.08%
2,928 $104,000
Q1 2018

May 15, 2018
BUY
$7.19 - $33.17 $13,488 - $62,226
1,876 New
1,876 $14,000

Others Institutions Holding SLDB

# of Institutions
2
Shares Held
97
Call Options Held
0
Put Options Held
0
View Full List

About Solid Biosciences Inc.

SLDB Quotes by TradingView
  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $24.3M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email